Erlotinib/gefitinibHair and scalp changes: 13 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2013年 / 1470卷 / 1期

关键词：

D O I：

10.1007/s40278-013-5977-2

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：21 / 21

相关论文

共 50 条

[21] Erlotinib/gefitinibHepatotoxicity and skin rash: 7 case reports
Reactions Weekly, 2015, 1572 (1) : 91 - 91
[22] Cetuximab/erlotinib/panitumumabSkin rash: 3 case reports
Reactions Weekly, 2017, 1634 (1) : 64 - 64
[23] Erlotinib/gemcitabineInterstitial lung disease: 4 case reports
Reactions Weekly, 2015, 1543 (1) : 95 - 95
[24] Erlotinib/gefitinibPurpuric drug eruption: 3 case reports
Reactions Weekly, 2020, 1786 (1) : 80 - 80
[25] Erlotinib/panitumumabOcular adverse events: 5 case reports
Reactions Weekly, 2012, 1426 (1) : 22 - 22
[26] Afatinib/erlotinib/gefitinibVarious toxicities: 22 case reports
Reactions Weekly, 2020, 1802 (1) : 16 - 16
[27] Erlotinib/gefitinibInterstitial lung disease: 20 case reports
Reactions Weekly, 2011, 1375 (1) : 15 - 15
[28] Erlotinib/vandetanibHypocalcaemia due to hypoparathyroidism: 2 case reports
Reactions Weekly, 2020, 1799 (1) : 170 - 170
[29] Erlotinib/osimertinibAcquired drug resistance: 2 case reports
Reactions Weekly, 2019, 1753 (1) : 161 - 161
[30] Erlotinib/gemcitabineInterstitial lung disease: 2 case reports
Reactions Weekly, 2017, 1680 (1) : 131 - 131

← 1 2 3 4 5 →